Journal: Scientific Reports
Article Title: DLGAP4 acts as an effective prognostic predictor for hepatocellular carcinoma and is closely related to tumour progression
doi: 10.1038/s41598-022-23837-y
Figure Lengend Snippet: Interfering with DLGAP4 inhibits the PPARβ/δ signalling pathway and the expression of proliferation- and metastasis-related proteins. Western blotting was performed to measure the protein expression of DLGAP4, PPARβ/δ, CyclinD1, E-cadherin and N-cadherin in shNC or shDLGAP4 HepG2 and HCCLM3 cells. The data were obtained from the average of three independent experiments. *P < 0.05.
Article Snippet: The following antibodies were used: rabbit PPARβ/δ monoclonal antibody (1:2000, Abcam, Cambridge, MA, USA), mouse β-actin polyclonal antibody (1:1000, Boster Biological Technology, Ltd), rabbit E-cadherin polyclonal antibody (1:1000, Boster Biological Technology, Ltd), rabbit N-cadherin polyclonal antibody (1:1000, Boster Biological Technology, Ltd), rabbit DLGAP4 polyclonal antibody (1:1000, Abcam, Cambridge, MA, USA), and rabbit CyclinD1 polyclonal antibody (1:1000, Boster Biological Technology, Ltd.).
Techniques: Expressing, Western Blot